| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $722.5M | — | +3.9% |
| Cost of Revenue | $402.4M | — | -8.4% |
| Gross Profit | $320.1M | — | +25.1% |
| R&D Expense | $38.4M | — | -4.1% |
| SG&A Expense | $138.9M | — | +17.4% |
| Operating Income | $141.8M | — | +41.3% |
| Pre-tax Income | $80.2M | — | +113.9% |
| Income Tax | $2.2M | — | -83.1% |
| Net Income | $62.3M | — | +410.5% |
| EPS (Basic) | $0.20 | — | +400.0% |
| EPS (Diluted) | $0.19 | — | +375.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $197.7M | -29.9% | +234.0% |
| Inventory | $641.6M | +5.8% | +6.7% |
| Current Assets | $1.80B | -5.9% | +19.0% |
| Total Assets | $3.54B | -3.8% | +5.2% |
| Current Liabilities | $728.0M | -17.4% | -32.3% |
| Long-term Debt | $2.57B | -0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$26.7M | — | -461.0% |
| Capital Expenditures | $8.2M | — | -37.9% |
| Investing Cash Flow | -$21.7M | — | -22.0% |
| Financing Cash Flow | -$59.1M | — | -50.8% |
| Free Cash Flow | -$34.9M | — | -506.8% |
| +17.7% |
| Stockholders' Equity | -$45.4M | +35.9% | +65.5% |